1. Home
  2. MNDR vs AZTR Comparison

MNDR vs AZTR Comparison

Compare MNDR & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

HOLD

Current Price

$1.16

Market Cap

2.7M

Sector

N/A

ML Signal

HOLD

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.28

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDR
AZTR
Founded
2016
2014
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
3.1M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
MNDR
AZTR
Price
$1.16
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
600.7K
1.4M
Earning Date
10-31-2025
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,646,739.00
N/A
Revenue This Year
$608,852.40
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$0.26
52 Week High
$40.00
$3.92

Technical Indicators

Market Signals
Indicator
MNDR
AZTR
Relative Strength Index (RSI) 47.89 43.07
Support Level $1.01 $0.26
Resistance Level $1.23 $0.29
Average True Range (ATR) 0.19 0.03
MACD 0.04 0.00
Stochastic Oscillator 22.18 19.79

Price Performance

Historical Comparison
MNDR
AZTR

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: